{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T05:01:51Z","timestamp":1694926911467},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.braindev.2013.04.006","type":"journal-article","created":{"date-parts":[[2013,5,3]],"date-time":"2013-05-03T17:49:40Z","timestamp":1367603380000},"page":"194-202","source":"Crossref","is-referenced-by-count":9,"title":["The efficacy of gabapentin in children of partial seizures and the blood levels"],"prefix":"10.1016","volume":"36","author":[{"given":"Yutaka","family":"Nonoda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2013.04.006_b0005","doi-asserted-by":"crossref","first-page":"e519","DOI":"10.1542\/peds.2006-1609","article-title":"Gabapentin successfully manages chronic unexplained irritability in children with severe neurologic impairment","volume":"119","author":"Hauer","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.braindev.2013.04.006_b0010","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/BPO.0b013e318070cc4d","article-title":"Pediatric complex regional pain syndrome","volume":"27","author":"Low","year":"2007","journal-title":"J Pediatr Orthop"},{"key":"10.1016\/j.braindev.2013.04.006_b0015","first-page":"178","article-title":"The effect of vigabatrin, lamotrigine and gabapentin of the fertility, weights, sex hormones and biochemical profiles of male rats","volume":"25","author":"Daoud","year":"2004","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.braindev.2013.04.006_b0020","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2165\/00002018-200124130-00004","article-title":"Bodyweight gain and anticonvulsants. A comparative review","volume":"24","author":"Jallon","year":"2001","journal-title":"Drug safety"},{"key":"10.1016\/j.braindev.2013.04.006_b0025","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.pediatrneurol.2007.03.001","article-title":"Antiepileptic drugs and visual function","volume":"36","author":"Verrotti","year":"2007","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.braindev.2013.04.006_b0030","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/j.1556-4029.2011.01798.x","article-title":"Suicide by gabapentin overdose","volume":"56","author":"Middleton","year":"2011","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.braindev.2013.04.006_b0035","doi-asserted-by":"crossref","first-page":"910","DOI":"10.2146\/ajhp090313","article-title":"Withdrawal symptoms after gabapentin discontinuation","volume":"67","author":"Hellwig","year":"2010","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.braindev.2013.04.006_b0040","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/0091270010368411","article-title":"Pharmacokinetics of gabapentin in a novel gastric-retentive extended-release formulation: comparison with an immediate-release formulation and effect of dose escalation and food","volume":"51","author":"Chen","year":"2011","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.braindev.2013.04.006_b0045","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.clinthera.2009.07.026","article-title":"Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers","volume":"31","author":"Lal","year":"2009","journal-title":"Clin Ther"},{"key":"10.1016\/j.braindev.2013.04.006_b0050","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/bjp.2008.27","article-title":"Gabapentin evoked changes in functional activity in nociceptive regions in the brain of the anaesthetized rat: an fMRI study","volume":"153","author":"Governo","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.braindev.2013.04.006_b0055","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.braindev.2008.01.007","article-title":"New antiepileptic drugs in pediatric epilepsy","volume":"30","author":"Hwang","year":"2008","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2013.04.006_b0060","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.tips.2006.12.006","article-title":"Ca2+ channel \u03b12\u03b4 ligands: novel modulators of neurotransmission","volume":"28","author":"Dooley","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.braindev.2013.04.006_b0065","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.coph.2005.11.003","article-title":"The mechanisms of action of gabapentin and pregabalin","volume":"6","author":"Sills","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.braindev.2013.04.006_b0070","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2710.2004.00596.x","article-title":"Pharmacokinetics of gabapentin in paediatric patients with uncontrolled seizures","volume":"29","author":"Tallian","year":"2004","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.braindev.2013.04.006_b0075","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0028-3908(00)00103-9","article-title":"Anticonvulsant action and long-term effects of gabapentin in the immature brain","volume":"40","author":"Cilio","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.braindev.2013.04.006_b0080","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0387-7604(01)00230-3","article-title":"Newer antiepileptic drugs: advantages and disadvantages","volume":"23","author":"Wallace","year":"2001","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2013.04.006_b0085","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1472-8206.2001.00055.x","article-title":"Clinical pharmacology and therapeutic use of the new antiepileptic drugs","volume":"15","author":"Perucca","year":"2001","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.braindev.2013.04.006_b0090","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.aca.2010.03.028","article-title":"Hollow fiber-based liquid phase microextraction combined with high-performance liquid chromatography for the analysis of gabapentin in biological samples","volume":"665","author":"Ebrahimzadeh","year":"2010","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.braindev.2013.04.006_b0095","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00216-010-4048-2","article-title":"Dried plasma spots as an alternative sample collection technique for the quantitative LC-MS\/MS determination of gabapentin","volume":"398","author":"Kolocouri","year":"2010","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.braindev.2013.04.006_b0100","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/chromsci\/47.10.868","article-title":"Validated LC-MS-MS method for the determination of gabapentin in human plasma: application to a bioequivalence study","volume":"47","author":"Wattananat","year":"2009","journal-title":"J Chromatogr Sci"},{"key":"10.1016\/j.braindev.2013.04.006_b0105","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jpba.2006.05.012","article-title":"Determination of gabapentin in human plasma and urine by high-performance liquid chromatography with UV-vis detection","volume":"42","author":"Sagirli","year":"2006","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.braindev.2013.04.006_b0110","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/rcm.2573","article-title":"Determination of gabapentin in human plasma using hydrophilic interaction liquid chromatography with tandem mass spectrometry","volume":"20","author":"Ji","year":"2006","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1016\/j.braindev.2013.04.006_b0115","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cccn.2004.11.023","article-title":"Quantitative determination of vigabatrin and gabapentin in human serum by gas chromatography-mass spectrometry","volume":"354","author":"Borrey","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.braindev.2013.04.006_b0120","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2125.2005.02529.x","article-title":"Clinically relevant drug interactions with antiepileptic drugs","volume":"61","author":"Perucca","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.braindev.2013.04.006_b0125","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00007691-200302000-00008","article-title":"Plasma gabapentin levels in children with epilepsy: influence of age, relationship with dosage, and preliminary observations on correlation with clinical response","volume":"25","author":"Gatti","year":"2003","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.braindev.2013.04.006_b0130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/seiz.1999.0340","article-title":"Conversion from thrice daily to twice daily administration of gabapentin (GBP) in partial epilepsy: analysis of clinical efficacy and plasma levels","volume":"9","author":"Muscas","year":"2000","journal-title":"Seizure"},{"key":"10.1016\/j.braindev.2013.04.006_b0135","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1528-1157.1994.tb02513.x","article-title":"Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. The international gabapentin study group","volume":"35","author":"Anhut","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2013.04.006_b0140","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1111\/j.1528-1157.1994.tb05974.x","article-title":"Gabapentin as add-on therapy for refractory partial epilepsy: results of five placebo-controlled trials","volume":"35","author":"Leiderman","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2013.04.006_b0145","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1528-1157.1997.tb01251.x","article-title":"The new antiepileptic drugs: a systematic review of their efficacy and tolerability","volume":"38","author":"Marson","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2013.04.006_b0150","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1528-1157.1999.tb00833.x","article-title":"Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study","volume":"40","author":"Appleton","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2013.04.006_b0155","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1111\/j.1528-1167.2005.00251.x","article-title":"Pharmacokinetics of gabapentin during delivery, in the neonatal period, and lactation: does a fetal accumulation occur during pregnancy?","volume":"46","author":"\u00d6hman","year":"2005","journal-title":"Epilepsia"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760413001551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760413001551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T06:50:28Z","timestamp":1539672628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760413001551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0387760413001551"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2013.04.006","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}